Elutia (ELUT) Depreciation & Amortization (CF) (2019 - 2026)
Elutia's (ELUT) quarterly Depreciation & Amortization (CF) came in at $349000.0 in Q2 2026, down 60.87% year-over-year from $892000.0 in Q2 2025, and up 5.76% quarter-over-quarter from $330000.0 in Q1 2026.
Analysis
Elutia (ELUT) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends
Elutia has disclosed Depreciation & Amortization (CF) across 8 years of filings, most recently posting $349000.0 for Q2 2026.
- In Q2 2026, Depreciation & Amortization (CF) fell 60.87% year-over-year to $349000.0; the TTM figure through Jun 2026 stood at $1.7 million (down 51.1% YoY), while the FY2025 annual figure was $2.8 million, down 19.3% from the prior year.
- Depreciation & Amortization (CF) came in at $349000.0 for Q2 2026 at Elutia, up from $330000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $954000.0 in Q2 2023 to a low of $297000.0 in Q4 2025.
- Average Depreciation & Amortization (CF) over 5 years is $799777.8, with a median of $880000.0 recorded in 2025.
- The largest YoY upside for Depreciation & Amortization (CF) was 3.48% in 2025 against a maximum downside of 65.59% in 2025.
- Over 5 years, Depreciation & Amortization (CF) stood at $937000.0 in 2022, then dropped by 4.59% to $894000.0 in 2023, then dropped by 3.47% to $863000.0 in 2024, then slumped by 65.59% to $297000.0 in 2025, then increased by 17.51% to $349000.0 in 2026.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $349000.0 in Q2 2026, $330000.0 in Q1 2026, and $297000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 192.30 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 729.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 355.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 42.70 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 68.20 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Elutia | 35.28 Mn | 15.39 Mn | 1.45 Mn | 349,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 349,000.00 |
| Mar 31, 2026 | 330,000.00 |
| Dec 31, 2025 | 297,000.00 |
| Sep 30, 2025 | 728,000.00 |
| Jun 30, 2025 | 892,000.00 |
| Mar 31, 2025 | 868,000.00 |
| Dec 31, 2024 | 863,000.00 |
| Sep 30, 2024 | 862,000.00 |
| Jun 30, 2024 | 862,000.00 |
| Mar 31, 2024 | 864,000.00 |
| Dec 31, 2023 | 894,000.00 |
| Sep 30, 2023 | 953,000.00 |
| Jun 30, 2023 | 954,000.00 |
| Mar 31, 2023 | 947,000.00 |
| Dec 31, 2022 | 937,000.00 |
| Sep 30, 2022 | 933,000.00 |
| Jun 30, 2022 | 934,000.00 |
| Mar 31, 2022 | 929,000.00 |
| Dec 31, 2021 | 933,000.00 |
| Sep 30, 2021 | 932,000.00 |